Kytril Lawsuit

Kytril Lawsuit

Kytril Lawsuit

A Brief Guide to Filing a Kytril Lawsuit

The prescription medication Kytril alleviates nausea and vomiting for patients undergoing chemotherapy treatment. Kytril side effects are uncommon and have not been reported to lead to any fatalities. At this time, most personal injury or drug lawyers are not actively pursuing the opportunity to handle a Kytril lawsuit due to the drug's relatively safe use.

However, two significant legal actions have been taken against the drug: In 2007, a federal Kytril lawsuit concerning manufacturer fraud in raising the wholesale price reached a settlement; these charges did not relate to Kytril side effects in any way. Instead, GlaxoSmithKline set aside 30% of a $70 million settlement negotiated during this Kytril lawsuit to compensate consumers who had been overcharged between 1991 and January 1st of 2005. Claims for compensation were processed and resolved by 2009.

The other famous suit, a 2004 filing reached a settlement the following year. A GlaxoSmithKline plant based in Puerto Rico was found guilty in 2010 of having regularly manufactured medication incorrectly. Though no Kytril side effects were reported as the result of consuming medication, the company was fined heavily for fraudulent sales of defective medication from 2001 to 2004. All settlement money relating to this Kytril lawsuit has been disbursed.None of this litigation concerned Kytril side effects, subsequently no significant Kytril lawsuit has been reported concerning these issues.

The primary Kytril side effect to be aware of revolves around allergic reactions—if you notice any unusual swelling or congestion you should discontinue use.

It is possible that the faulty manufacturing of the drug may lead to similar cases or recalls in the future. If so, consumers experiencing adverse effects must provide copies of their prescription purchase receipt to demonstrate that their medication came from a compromised or tainted batch.

Serious Kytril side effects that are misrepresented should be reported to the FDA. However, at this time the FDA is not pursuing an investigation regarding potentially serious and underreported Kytril side effects.

If such an event occurs, it is important to make sure that all complications are documented by a medical professional. The delivery of documentation affirming the presence of Kytril side effects is a prerequisite for an attorney to consider filing suit. Such an evaluation can only be made by a pharmaceutical attorney experienced in handling similar cases.

Kytril FDA Regulations:

The United States Food and Drug Administration has stated that an adequate QT assessment has not been conducted, but QT prolongation has been reported with Kytril. Therefore, Kytril should be administered with caution to patients with pre-existing arrhythmias or cardiac conduction disorders. Patients with cardiac disease, cardiac conduction disorders or pre-existing arrhythmias may lead to clinical consequences.

Kytril Side Effects:

•  Headache (observed in up to 21 percent of people)

•  Constipation (observed in up to 18 percent of people)

• Fatigue/Weakness (observed in up to 18 percent of people)

• Abdominal Pain (observed in up to 6 percent of people)

•  Insomina (Observed n up to 5 percent of people)

•  Hair Loss (observed in up to 3 percent of people)



1. United States National Library of Medicine "Granisetron" retrieved from:





Related Articles